Wadler to head MWW health offering

MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.

Wadler, who was previously chief strategic officer and global healthcare practice chair for Burson-Marsteller, is charged with leading the strategic direction of the agency, along with the global healthcare practice for MWW Group.

She will also assume responsibility for devising new thought leadership platforms for the agency and driving practice integration across all platforms.

Kempner said: “Ame will be leveraging that vast experience and expertise to expand our senior management team structure and scale the agency's operations and management framework for continued growth, both domestically and abroad.”

At Burson, Wadler is credited with overseeing the launches of Botox Cosmetic, Enbrel and the reintroduction of silicone gel breast implants to the US.

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.